0001127602-20-030240.txt : 20201201 0001127602-20-030240.hdr.sgml : 20201201 20201201170652 ACCESSION NUMBER: 0001127602-20-030240 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201130 FILED AS OF DATE: 20201201 DATE AS OF CHANGE: 20201201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zaks Tal Zvi CENTRAL INDEX KEY: 0001690927 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 201361549 MAIL ADDRESS: STREET 1: 122 BELLEVUE STREET CITY: NEWTON STATE: MA ZIP: 02458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-11-30 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2020-11-30 4 M 0 5000 12.21 A 5000 D Common Stock 2020-11-30 4 M 0 5000 14.22 A 10000 D Common Stock 2020-11-30 4 M 0 10000 19.15 A 20000 D Common Stock 2020-11-30 4 S 0 800 142.43 D 19200 D Common Stock 2020-11-30 4 S 0 600 144.09 D 18600 D Common Stock 2020-11-30 4 S 0 1660 145.25 D 16940 D Common Stock 2020-11-30 4 S 0 2108 146.12 D 14832 D Common Stock 2020-11-30 4 S 0 3335 147.22 D 11497 D Common Stock 2020-11-30 4 S 0 5893 148.35 D 5604 D Common Stock 2020-11-30 4 S 0 4100 149.38 D 1504 D Common Stock 2020-11-30 4 S 0 700 150.09 D 804 D Common Stock 2020-11-30 4 S 0 100 151.00 D 704 D Common Stock 2020-11-30 4 S 0 312 152.74 D 392 D Common Stock 2020-11-30 4 S 0 392 153.50 D 0 D Stock Option (Right to Buy) 12.21 2020-11-30 4 M 0 5000 0 D 2027-02-23 Common Stock 5000 12945 D Stock Option (Right to Buy) 14.22 2020-11-30 4 M 0 5000 0 D 2028-02-28 Common Stock 5000 55209 D Stock Option (Right to Buy) 19.15 2020-11-30 4 M 0 10000 0 D 2026-08-10 Common Stock 10000 24790 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.21 to $142.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.63 to $144.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.65 to $145.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.67 to $146.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.70 to $147.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.85 to $148.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.93 to $149.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.94 to $150.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.35 to $153.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.40 to $153.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. This option is fully vested and exercisable. /s/ Lori Henderson, as Attorney-in-Fact 2020-12-01